BNGO · Categories · Form 4

BNGO - SEC Form 4 insider transactions

Bionano Genomics Inc. (BNGO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BNGO

• 7d
  GENERAL COUNSEL Dixon Jonathan V. covered exercise/tax liability with 24 shares, decreasing direct ownership by 9% to 239 units (SEC Form 4) (for withholding tax)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 7d
  CHIEF OPERATING OFFICER Oldakowski Mark covered exercise/tax liability with 27 shares, decreasing direct ownership by 3% to 868 units (SEC Form 4) to satisfy withholding tax

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 7d
  CHIEF MEDICAL OFFICER Chaubey Alka covered exercise/tax liability with 24 shares, decreasing direct ownership by 4% to 620 units (SEC Form 4) (for withholding tax)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 7d
  Principal Accounting Officer Adamchak Mark covered exercise/tax liability with 7 shares, decreasing direct ownership by 3% to 253 units (SEC Form 4) (withholding obligation)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 27d
  SEC Form 4 filed by Director Rajkovic Aleksandar

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 27d
  SEC Form 4 filed by Director Linney Yvonne

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 27d
  SEC Form 4 filed by Director Vuori Kristiina Md

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 27d
  SEC Form 4 filed by Director Twomey Christopher J

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 27d
  SEC Form 4 filed by Director Barker David L

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 112d
  CHIEF MEDICAL OFFICER Chaubey Alka covered exercise/tax liability with 18 shares, decreasing direct ownership by 3% to 644 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 112d
  Principal Accounting Officer Adamchak Mark covered exercise/tax liability with 3 shares, decreasing direct ownership by 1% to 260 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 112d
  GENERAL COUNSEL Dixon Jonathan V. covered exercise/tax liability with 6 shares, decreasing direct ownership by 2% to 263 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 112d
  CHIEF OPERATING OFFICER Oldakowski Mark covered exercise/tax liability with 20 shares, decreasing direct ownership by 2% to 895 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 112d
  PRESIDENT AND CEO Holmlin R. Erik covered exercise/tax liability with 51 shares, decreasing direct ownership by 3% to 1,657 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 126d
  SEC Form 4 filed by Principal Accounting Officer Adamchak Mark

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Chaubey Alka

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Oldakowski Mark

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 126d
  SEC Form 4 filed by GENERAL COUNSEL Dixon Jonathan V.

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 126d
  SEC Form 4 filed by PRESIDENT AND CEO Holmlin R. Erik

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 271d
  Amendment: Chief Operating Officer Oldakowski Mark covered exercise/tax liability with 59 shares, decreasing direct ownership by 6% to 915 units (SEC Form 4)

  4/A - Bionano Genomics, Inc. (0001411690) (Issuer)
• 271d
  Chief Operating Officer Oldakowski Mark covered exercise/tax liability with 59 shares, decreasing direct ownership by 6% to 915 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 271d
  Chief Medical Officer Chaubey Alka covered exercise/tax liability with 51 shares, decreasing direct ownership by 7% to 662 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 363d
  SEC Form 4 filed by Director Twomey Christopher J

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 363d
  SEC Form 4 filed by Director Vuori Kristiina Md

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 363d
  SEC Form 4 filed by Director Linney Yvonne

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 363d
  SEC Form 4 filed by Director Luderer Albert

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 363d
  SEC Form 4 filed by Director Barker David L

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 363d
  SEC Form 4 filed by Director Mamuszka Hannah

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 363d
  SEC Form 4 filed by Director Rajkovic Aleksandar

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 372d
  Chief Operating Officer Oldakowski Mark covered exercise/tax liability with 27 shares, decreasing direct ownership by 3% to 974 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 372d
  Principal Accounting Officer Adamchak Mark covered exercise/tax liability with 7 shares, decreasing direct ownership by 3% to 263 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 372d
  Chief Medical Officer Chaubey Alka covered exercise/tax liability with 24 shares, decreasing direct ownership by 3% to 713 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 372d
  President and CEO Holmlin R. Erik covered exercise/tax liability with 75 shares, decreasing direct ownership by 4% to 1,708 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 372d
  General Counsel Dixon Jonathan V. covered exercise/tax liability with 25 shares, decreasing direct ownership by 9% to 269 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 449d
  SEC Form 4 filed by General Counsel Dixon Jonathan V.

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 449d
  SEC Form 4 filed by Principal Accounting Officer Adamchak Mark

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 449d
  President and CEO Holmlin R. Erik covered exercise/tax liability with 198 shares, decreasing direct ownership by 10% to 1,783 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 449d
  SEC Form 4 filed by Chief Operating Officer Oldakowski Mark

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 449d
  SEC Form 4 filed by Chief Medical Officer Chaubey Alka

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 476d
  Chief Operating Officer Oldakowski Mark covered exercise/tax liability with 20 shares, decreasing direct ownership by 2% to 1,001 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 476d
  General Counsel Dixon Jonathan V. covered exercise/tax liability with 6 shares, decreasing direct ownership by 2% to 294 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 476d
  President and CEO Holmlin R. Erik covered exercise/tax liability with 51 shares, decreasing direct ownership by 3% to 1,981 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 476d
  Chief Medical Officer Chaubey Alka covered exercise/tax liability with 18 shares, decreasing direct ownership by 2% to 737 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 476d
  Principal Accounting Officer Adamchak Mark covered exercise/tax liability with 4 shares, decreasing direct ownership by 1% to 270 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 616d
  SEC Form 4 filed by Principal Accounting Officer Adamchak Mark

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 635d
  Chief Operating Officer Oldakowski Mark covered exercise/tax liability with 3,568 shares, decreasing direct ownership by 6% to 61,283 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 635d
  Chief Medical Officer Chaubey Alka covered exercise/tax liability with 3,075 shares, decreasing direct ownership by 6% to 45,323 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Rajkovic Aleksandar

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Luderer Albert

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Vuori Kristiina Md

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Barker David L

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Wong Vincent Jung-Fai

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Mamuszka Hannah

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Twomey Christopher J

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 720d
  SEC Form 4 filed by Director Linney Yvonne

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 735d
  Oldakowski Mark was granted 16,000 shares, increasing direct ownership by 33% to 64,698 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 735d
  Kama Gulsen was granted 16,000 shares (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 735d
  Holmlin R. Erik was granted 44,000 shares, increasing direct ownership by 57% to 121,813 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 735d
  Dixon Jonathan V. was granted 14,500 shares, increasing direct ownership by 411% to 18,025 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)
• 735d
  Chaubey Alka was granted 16,000 shares, increasing direct ownership by 50% to 48,245 units (SEC Form 4)

  4 - Bionano Genomics, Inc. (0001411690) (Issuer)

Other BNGO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends